Brexit and pandemic double whammy: NHS staff retention crisis examined
NCT ID NCT05276427
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how Brexit and the COVID-19 pandemic impacted the decision of nurses and consultants to stay or leave their jobs at NHS Grampian in Scotland. Researchers interviewed 30 staff members who were employed before January 2020 to understand their experiences. The goal is to help hospital management and policymakers find ways to keep valuable healthcare workers from leaving.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
30 people
The number who actually took part.
- Started
-
Apr 2022
- Finished
-
May 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Nurses who have been trained in different aspects of nursing such as paediatric, neonatal, critical care, surgical, emergency care etc and consultants who have specialist training in specific aspect of medicine who have had to deal with the impact and pressures of COVID 19 and BREXIT will be invited to participate in the study.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Must be employed in NHS Grampian prior to January 2020. * Must be a Nurse or Consultant Exclusion Criteria: * Limited to Nurses and Consultants.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Turnover are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research and governance team
Aberdeen, United Kingdom